Caliber Imaging & Diagnostics, Inc. (LCDX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 15, 2025
LCDX Revenue
Caliber Imaging & Diagnostics had revenue of $858.14K in the quarter ending March 31, 2014, a decrease of -18.94%. This brings the company's revenue in the last twelve months to $3.14M, down -1.09% year-over-year. In the year 2013, Caliber Imaging & Diagnostics had annual revenue of $3.34M with 37.24% growth.
Revenue (ttm)
3.14M
Revenue Growth
-1.09%
P/S Ratio
0.00
Revenue / Employee
112.17K
Employees
28
Market Cap
858.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2013 | 3.34M | 906.67K | 37.24% |
| Dec 31, 2012 | 2.43M | -1.14M | -31.94% |
| Dec 31, 2011 | 3.58M | 950.09K | 36.17% |
| Dec 31, 2010 | 2.63M | 324.25K | 14.08% |
| Dec 31, 2009 | 2.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |